Klotho Neurosciences, Inc.
$1.60
(as of Jun 13, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Ticker Information for Klotho Neurosciences, Inc.
Stock Price
$1.60
Ticker Symbol
KLTO
Exchange
NASDAQ
Industry Information for Klotho Neurosciences, Inc.
Sector
Healthcare
Industry
Biotechnology
Company Description for Klotho Neurosciences, Inc.
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates comprise KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
Fundamentals for Klotho Neurosciences, Inc.
Market Capitalization
$17,646,580
EBITDA
Dividends per Share
P/E Ratio
Forward P/E Ratio
0
Earnings per Share
$0
Earnings per Share Estimate Next Year
Profit Margin
Shares Outstanding
21,263,500
Percent Owned by Insiders
80.25%
Percent Owned by Institutions
14.46%
52-Week High
52-Week Low
Technical Indicators for Klotho Neurosciences, Inc.
Analyst Ratings for Klotho Neurosciences, Inc.
Strong Buy
Buy
Hold
Sell
Strong Sell
News About Klotho Neurosciences, Inc.
Jun 13, 2025, 3:00 PM EST
[A double exposure image of skyscrapers with overlay of financial graphs, set against a blurred background, illustrating the concept of business growth]
See more.